NDC 0143-9299

Ganciclovir

Ganciclovir Sodium

Ganciclovir is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc.. The primary component is Ganciclovir Sodium.

Product ID0143-9299_0fff71bc-b705-4d81-ab82-83f218f3160d
NDC0143-9299
Product TypeHuman Prescription Drug
Proprietary NameGanciclovir
Generic NameGanciclovir Sodium
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-06-17
Marketing CategoryANDA /
Application NumberANDA076222
Labeler NameHikma Pharmaceuticals USA Inc.
Substance NameGANCICLOVIR SODIUM
Active Ingredient Strength50 mg/mL
Pharm ClassesCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0143-9299-10

10 VIAL in 1 BOX (0143-9299-10) > 10 mL in 1 VIAL (0143-9299-01)
Marketing Start Date2021-06-17
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Ganciclovir" or generic name "Ganciclovir Sodium"

NDCBrand NameGeneric Name
0143-9299GanciclovirGanciclovir sodium
14335-030Ganciclovirganciclovir sodium
24201-500GanciclovirGanciclovir
25021-185ganciclovirganciclovir sodium
42023-173GanciclovirGanciclovir
51754-2500GANCICLOVIRGANCICLOVIR
51817-171Ganciclovirganciclovir sodium
63304-636GANCICLOVIRGANCICLOVIR
63304-637GANCICLOVIRGANCICLOVIR
63323-315GanciclovirGANCICLOVIR SODIUM
70436-089Ganciclovirganciclovir sodium
76233-072GanciclovirGanciclovir Sodium
0004-6940Cytoveneganciclovir sodium
61269-450Cytoveneganciclovir sodium
24208-535ZIRGANganciclovir

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.